DV
Dividend Vision

AVR — Anteris Technologies Global Corp. Common Stock

Anteris Technologies Global Corp. Common Stock (AVR)

Total return is 56.7% over the past 1.7 years, 25.6 points ahead of SPY at 31.1%. Its deepest 1-year drawdown was 46.8%.

Anteris Technologies Global Corp. is an Australian structural heart company that develops and commercializes minimally invasive medical devices for treating heart valve diseases, including its DurAVR transcatheter aortic valve system, ADAPT anti-calcification tissue technology, and ComASUR delivery system. The company does not currently distribute dividends. This security appeals to investors seeking exposure to medical device innovation in the cardiovascular space rather than current income.

AVR key facts

Asset type
Stock
Asset class
Equity
Inception date
12/12/2024
Last close
$9.40
Market cap
$822,541,568
Average volume
683463.0
Beta
0.726
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.22